Loading data for CERT — first visit, this takes a few seconds.
Certara Inc. (CERT)
NasdaqGS: CERT
· Real-Time Price · USD
8.27
+0.26 (3.25%)
At close: Aug 19, 2026, 10:20 AM
Certara Inc. (CERT) Stock Price, Analysis & Data
3.25% (1D)
| Bid | 5.98 |
| Market Cap | 1.25B |
| Revenue (ttm) | 421.75M |
| Net Income (ttm) | -22.5M |
| Beta | 1.41 |
| EPS (ttm) | -0.14 |
| PE Ratio (ttm) | n/a |
| Forward PE | 20.99 |
| P/B (ttm) | 1.29 |
| P/S (ttm) | 2.97 |
| Earnings Date | Nov 5, 2026 |
| Ask | 10.36 |
| Volume | 1,098,602 |
| Avg. Volume (20D) | 4,274,706 |
| Open | 8.11 |
| Previous Close | 8.01 |
| Day's Range | 8.09 - 8.37 |
| 52-Week Range | 4.45 - 13.88 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About CERT
Certara, Inc., together with its subsidiaries, provides technology-driven services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the Americas, Europe, the Middle East, Africa, and Asia Pacific. It offers model-informed drug development solutions; biosimulation solutions to predict pharmacokinetics and pharmacodynamics; Simcyp simulator, a mechanistic bios...
Industry Health Information Services
Sector Healthcare
IPO Date Dec 11, 2020
Employees 1,515
Stock Exchange NasdaqGS
Ticker Symbol CERT
Website https://www.certara.com
Financial Performance
In 2025, Certara's revenue was 418.84M, an increase of 8.75% compared to the previous year's 385.15M. Earnings were -1.59M, a decrease of -86.76%.
Financial StatementsEarnings Surprise
Certara has released their quarterly earnings on Aug 4, 2026:
Certara Inc. is scheduled to release its earnings on Nov 5, 2026, before market opens.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade
Page 1 of 2